When.com Web Search

  1. Ads

    related to: eye numbing drops name brands

Search results

  1. Results From The WOW.Com Content Network
  2. Tetracaine - Wikipedia

    en.wikipedia.org/wiki/Tetracaine

    Tetracaine is the T in TAC, a mixture of 5 to 12% tetracaine, 0.05% adrenaline, and 4 or 10% cocaine hydrochloride used in ear, nose, and throat surgery and in the emergency department where numbing of the surface is needed rapidly, especially when children have been injured in the eye, ear, or other sensitive locations.

  3. Trifluridine - Wikipedia

    en.wikipedia.org/wiki/Trifluridine

    Trifluridine (also called trifluorothymidine; abbreviation TFT or FTD [1]) is an anti-herpesvirus antiviral drug, used primarily as prescription eyedrops.It was sold under the trade name Viroptic by Glaxo Wellcome, now merged into GlaxoSmithKline.

  4. Is it safe to use eyedrops? What to know about the FDA warnings

    www.aol.com/news/safe-eyedrops-know-fda-warnings...

    The Food and Drug Administration recently cautioned consumers against using 27 different kinds of eyedrops — its third eyedrop-related warning this year — leading Americans to question whether ...

  5. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

    www.aol.com/full-list-recalled-eye-drops...

    Clear Eyes Once Daily, Eye Allergy Itch Relief: Not officially linked to any bacterial infection cases being traced by the CDC, the FDA has indicated this brand's manufacturer, Teva ...

  6. A blinding bacteria, four dead and an everyday brand blamed ...

    www.aol.com/blinding-bacteria-four-dead-everyday...

    People have had to have their eyes surgically removed due to the bacteria

  7. Visine - Wikipedia

    en.wikipedia.org/wiki/Visine

    Visine (/ ˌ v aɪ ˈ z iː n /), also known as Vispring, is a brand of eye drops produced by Kenvue. [1] Visine was first introduced in 1958 and was acquired by Pfizer in 1999. [2] [3] In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. [4]